Abstract | BACKGROUND: METHODS: We first describe four case reports of children with AION during PD treatment. We then review ten additional AION cases reported in the literature and compare these 14 affected patients with a control cohort of 59 non-affected patients in the Vienna PD registry. RESULTS: Significant risk factors for AION were identified as median age (4 vs. 27 months; p < 0.001), autosomal recessive polycystic kidney disease (28.6 vs. 3.4%; p = 0.01), anephric status (53.8 vs. 6.8%; p < 0.001) and low to normal blood pressure evidenced by the number of patients having to be treated with antihypertensive medications (14.3 vs. 62.7%; p = 0.01). Severe hypovolemia was reported in 50% of all cases. Outcome was visual loss with optic atrophy in nine patients; five patients had a good visual outcome. The major difference in treatment was a rapid bolus of saline within 12 h after the initial symptoms. CONCLUSIONS:
|
Authors | Stephanie Dufek, Markus Feldkoetter, Enrico Vidal, Mieczyslaw Litwin, Marion Munk, Andreas Reitner, Thomas Mueller-Sacherer, Christoph Aufricht, Klaus Arbeiter, Michael Boehm |
Journal | Pediatric nephrology (Berlin, Germany)
(Pediatr Nephrol)
Vol. 29
Issue 7
Pg. 1249-57
(Jul 2014)
ISSN: 1432-198X [Electronic] Germany |
PMID | 24488506
(Publication Type: Journal Article)
|
Topics |
- Adolescent
- Age Factors
- Child, Preschool
- Female
- Humans
- Hypotension
(complications)
- Infant
- Male
- Optic Neuropathy, Ischemic
(etiology, therapy)
- Peritoneal Dialysis
(adverse effects)
- Polycystic Kidney, Autosomal Recessive
(complications)
- Risk Factors
|